Argan INC Form 4 insider transactions

Argan Inc. Chief Financial Officer Joshua Scott Baugher reported transactions involving the exercise of stock options and subsequent sale of shares.

Argan Inc. Director Peter W. Getsinger reports transactions involving the exercise of stock options and subsequent sale of common stock.

Argan Inc. Director Cynthia Flanders reported a sale of 2,596 shares of common stock.

Argan Inc. President and CEO David Watson reported significant transactions, including the sale of common stock and the exercise of stock options.

Director Cynthia Flanders reported a gift of 1,000 shares and the vesting of restricted stock units in Argan Inc.

Director Karen Sweeney acquired 533 shares of Argan Inc common stock through the vesting of restricted stock units.

Director William F. Leimkuhler acquired 533 shares of Argan Inc common stock through the vesting of restricted stock units and received a new grant of 189 units.

Director John R. Jeffrey Jr. acquired 533 shares of Argan, Inc. common stock through the vesting of restricted stock units and received a new grant of 189 units.

Director Peter W. Getsinger reported the sale of 3,000 shares of Argan, Inc. common stock and a gift of 500 shares.

Argan Inc. Director Lisa Larroque reported the sale of 350 shares of common stock on the open market.

Director William F. Leimkuhler reported the sale of 5,800 shares of ARGAN Inc. common stock on April 28, 2026, across personal and trust accounts.

Argan Inc. Director Jeffrey John Ronald Jr. reported a sale of 2,698 shares of common stock.

Argan, Inc. CEO Charles E. Collins IV exercised multiple stock options and subsequently sold shares on the open market.

Director John R. Jeffrey Jr. exercised stock options and sold shares of Argan, Inc. common stock on April 21, 2026.

Argan, Inc. CEO Charles Edwin Collins IV acquired 9,314 shares of common stock through the vesting of performance and time-based restricted stock units.

Argan Inc. President and CEO David Watson acquired shares through equity vesting and subsequently sold 19,310 shares.

Argan Inc. CFO Joshua Scott Baugher reported the vesting of restricted stock units and a subsequent open market sale.

Director Lisa Larroque acquired 700 shares of Argan Inc common stock following the vesting of restricted stock units.

ARGAN Inc. director William F. Leimkuhler reported the sale of 8,444 shares of common stock on April 13, 2026.

Argan Inc. Chief Executive Officer, Charles Edwin Collins IV, was granted stock options and various forms of restricted stock units on April 8, 2026.

Argan Inc. President and CEO David Hibbert Watson received stock options and various forms of restricted stock units on April 8, 2026, as detailed in a Form 4 filing.

Argan Inc. reports the grant of Earnings Per Share Performance-Based Restricted Stock Units to Director William F. Griffin Jr., with vesting tied to future EPS growth.

Argan Inc. Chief Financial Officer Joshua Scott Baugher was granted stock options and various forms of restricted stock units on April 8, 2026.

Argan Inc. Director Jeffrey John Ronald Jr. reported a sale of 4,556 shares of common stock on March 31, 2026.

Argan Inc. Director John R. Jeffrey Jr. sold 5,000 shares of common stock for $360.78 per share as part of a pre-arranged Rule 10b5-1 trading plan.

Argan Director Cynthia Flanders sold 19,000 shares at $386.70 in a pre-planned transaction.

ARGAN Director John R. Jeffrey Jr. exercised stock options and subsequently sold a portion of his common stock holdings.

Argan Inc. Director William F. Leimkuhler sold 11,044 shares of common stock for approximately $4.2 million in a pre-planned transaction.

ARGAN Inc. Director Cynthia Flanders exercised multiple stock options on January 13, 2026, acquiring 26,079 shares of common stock under a Rule 10b5-1 plan.

ARGAN Inc. Director William F. Leimkuhler sold a total of 6,376 shares of common stock in two open market transactions in January 2026, executed under a Rule 10b5-1 plan.